Heterozygote advantage for HLA class-II type in hepatitis B virus infection

Article metrics

  • An Erratum to this article was published on 01 January 1998

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Hughes, A.L. & Nei, M. Nature 355, 402–403 (1992).

  2. 2

    Doherty, P.C. & Zinkernagel, R.M. Lancet 1, 1406–1409 (1975).

  3. 3

    Snell, G.D. Folia Biol. 14, 335–358 (1968).

  4. 4

    Gillespie, J.H. Theor. Popul. Biol. 27, 222–237 (1985).

  5. 5

    Takahata, N. & Nei, M. Genetics 124, 967–978 (1990).

  6. 6

    Hill, A.V.S. et al. Nature 352, 595–600 (1991).

  7. 7

    Thursz, M.R. et al. N. Engl. J. Med. 332, 1065 (1995).

  8. 8

    Almarri, A. & Batchelor, J.R. Lancet 344, 1194–1195 (1994).

  9. 9

    Chisari, F.V. & Ferrari, C. Annu. Rev. Immunol. 13, 29–60 (1995).

  10. 10

    Allison, A.C., Cold Spring Harbor Symp. Quant. Biol. 29, 137–149 (1964).

  11. 11

    Hill, A.V.S. et al. Proc. Natl. Acad. Sci. USA 89, 2277–2281 (1992).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading